LON:GNS - Genus Stock Price, News & Analysis

GBX 2,902
+22.00 (+0.76 %)
(As of 09/15/2019 10:06 AM ET)
Today's Range
2,855
Now: GBX 2,902
2,910
50-Day Range
2,506
MA: GBX 2,621.24
2,902
52-Week Range
2,090
Now: GBX 2,902
2,950
Volume45,056 shs
Average Volume78,154 shs
Market Capitalization£1.89 billion
P/E Ratio243.87
Dividend Yield1.00%
BetaN/A
Genus plc operates as an animal genetics company in North America, Latin America, rest of Europe, the Middle East, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Research and Development. It sells sows, boars, and semen to breed pigs with various characteristics for pork production under the PIC brand. The company also sells bull semen and embryos, which are delivered through artificial insemination to breed dairy and beef cattle with various characteristics for milk and beef production under the ABS, Genus, and Bovec brands. Read More…

Industry, Sector and Symbol

Industry Biotechnology
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone+44-1256-347100

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales£488.50 million
Cash FlowGBX 44.80 per share
Book ValueGBX 778.60 per share

Profitability

Miscellaneous

Employees2,900
Market Cap£1.89 billion
Next Earnings DateN/A
OptionableNot Optionable

Receive GNS News and Ratings via Email

Sign-up to receive the latest news and ratings for GNS and its competitors with MarketBeat's FREE daily newsletter.


Genus (LON:GNS) Frequently Asked Questions

What is Genus' stock symbol?

Genus trades on the London Stock Exchange (LON) under the ticker symbol "GNS."

How often does Genus pay dividends? What is the dividend yield for Genus?

Genus announced a dividend on Thursday, September 5th. Shareholders of record on Thursday, November 7th will be given a dividend of GBX 18.80 per share on Friday, November 29th. This represents a yield of 0.68%. The ex-dividend date is Thursday, November 7th. This is an increase from Genus's previous dividend of $8.90. The official announcement can be viewed at this link. View Genus' Dividend History.

What price target have analysts set for GNS?

6 brokerages have issued 12-month price objectives for Genus' shares. Their predictions range from GBX 2,500 to GBX 3,200. On average, they expect Genus' stock price to reach GBX 2,819.17 in the next twelve months. This suggests that the stock has a possible downside of 2.9%. View Analyst Price Targets for Genus.

What is the consensus analysts' recommendation for Genus?

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Genus in the last year. There are currently 1 hold rating and 5 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Genus.

Has Genus been receiving favorable news coverage?

News stories about GNS stock have been trending somewhat positive recently, InfoTrie Sentiment Analysis reports. InfoTrie rates the sentiment of press coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. Genus earned a media sentiment score of 0.9 on InfoTrie's scale. They also gave media coverage about the company a news buzz of 1.0 out of 10, meaning that recent press coverage is extremely unlikely to have an impact on the stock's share price in the near future. View News Stories for Genus.

Who are some of Genus' key competitors?

What other stocks do shareholders of Genus own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Genus investors own include Clinigen Group (CLIN), Glencore (GLEN), Tesco (TSCO), AstraZeneca (AZN), British American Tobacco Plc Ads (BATS), Dairy Crest Group (DCG), Debenhams (DEB), Diageo (DGE), Experian (EXPN) and Ferguson (FERG).

Who are Genus' key executives?

Genus' management team includes the folowing people:
  • Mr. Karim Bitar, CEO & Exec. Director (Age 54)
  • Mr. Stephen Wilson, Group Fin. Director & Exec. Director (Age 59)
  • Dr. Jonathan Lightner, Chief of R&D and Scientific Officer
  • Mr. Dan Hartley, Group Gen. Counsel & Company Sec.
  • Ms. Angelle R. Rosata, Group HR Director

How do I buy shares of Genus?

Shares of GNS and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Genus' stock price today?

One share of GNS stock can currently be purchased for approximately GBX 2,902.

How big of a company is Genus?

Genus has a market capitalization of £1.89 billion and generates £488.50 million in revenue each year. Genus employs 2,900 workers across the globe.View Additional Information About Genus.

What is Genus' official website?

The official website for Genus is http://www.genusplc.com/.

How can I contact Genus?

Genus' mailing address is Matrix House, Basing View, BASINGSTOKE, RG21 4DZ, United Kingdom. The company can be reached via phone at +44-1256-347100.


MarketBeat Community Rating for Genus (LON GNS)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  307 (Vote Outperform)
Underperform Votes:  266 (Vote Underperform)
Total Votes:  573
MarketBeat's community ratings are surveys of what our community members think about Genus and other stocks. Vote "Outperform" if you believe GNS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe GNS will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 9/15/2019 by MarketBeat.com Staff

Featured Article: Strike Price

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel